Therapy based on the incretin effect

Abstract

The question is not whether the normalization of blood glucose importance for reducing cardiovascular risk and mortality, but how normal glycemia reach safely.

Keywords

• incretins
• glyptins
• agonists of GLP-1
• incretin therapy
• cardiovascular risk